Role of Anti Mullerian Hormone for Ovarian Reserve Determination of Preoperative and Postoperative Endometrioma Patients
1 other identifier
observational
30
1 country
1
Brief Summary
Ovarian reserve influenced by many factor but especially cysts like endometrioma. Anti mullerian hormone is recent marker for ovarian reserve. The investigators are searching ovarian reserve pre and post operatively by using antimullerian hormone of endometrioma patient who are operated for their cysts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2013
CompletedFirst Submitted
Initial submission to the registry
November 6, 2013
CompletedFirst Posted
Study publicly available on registry
November 13, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2016
CompletedAugust 10, 2018
August 1, 2018
1 year
November 6, 2013
August 8, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Long term postoperative ovarian reserve outcomes of endometrioma patients by examining antimullerian hormone.
2 years
Study Arms (1)
Endmetrioma surgery
Eligibility Criteria
Females who are administring gynecology clinic suffering from symptomatic benign ovarian cysts.
You may qualify if:
- Ultrasonographical symptomatic and benign cysts which has surgery indication.
You may not qualify if:
- Over 42 years old, systemic endocrine disorder, history of ovarian surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kanuni Sultan Suleyman Education and Research Hospital
Istanbul, 34303, Turkey (Türkiye)
Biospecimen
We are collecting serum samples of pre and post operative endometroma patients and measuring anti müllerian hormone levels.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
November 6, 2013
First Posted
November 13, 2013
Study Start
May 1, 2012
Primary Completion
May 1, 2013
Study Completion
May 1, 2016
Last Updated
August 10, 2018
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will not share